Format

Send to

Choose Destination
Ann Hematol. 2016 Jun;95(7):1197-200. doi: 10.1007/s00277-016-2664-4. Epub 2016 Apr 11.

Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.

Author information

1
Department of Pathology, Brady Memorial Laboratory, Yale School of Medicine, 310 Cedar Street, New Haven, CT, 06510, USA. maximilian.stahl@yale.edu.
2
Department of Pathology, Brady Memorial Laboratory, Yale School of Medicine, 310 Cedar Street, New Haven, CT, 06510, USA.
3
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
4
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
PMID:
27068405
DOI:
10.1007/s00277-016-2664-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center